JC Medical

JC Medical

Helping doctors to save lives

Partnering with physician, saving life

Corporate Social Responsibility

Committed to the popularization of cardiovascular health information, helping patients understand and manage cardiovascular diseases, and building a healthy and harmonious society


Strict quality system supervision

With a strict quality system and the spirit of craftsmanship, we actively explore cutting-edge technology, improve the level of equipment, improve the process, and cast safe and reliable quality products.


Global Expansion of TAVR Vision

Jiecheng College was co-founded by Jiecheng Medical and many surgical experts across the country. It has continuously provided exclusive, practical and advanced education to physicians in various fields, and has become a highly popular professional TAVR training college. Jiecheng College is committed to allowing more experts to spread and improve their excellent foreign science and technology skills across the world, granting doctors with different experiences in different regions the best educational resources to help expand TAVR globally.

Learn More
Picture Name

Product Introduction


Transapical implant

Short transmission path combined with excellent human factors engineering design, four-step digital control key

Simple to get the best coaxiality, short learning curve

Learn more

J-VALVE heart valve

NMPA Approved for Simultaneous Effective Treatment of Severe Aortic Insufficiency

Interventional bioprosthetic heart valve products for dual indications of stenosis and stenosis.

Learn more
Picture Name

Products under research

Transvascular interventional biological aortic valve system

About JC Medical

Suzhou Jiecheng Medical Technology Co., Ltd. was established in September 2009. It is a high-tech enterprise focusing on the R&D and manufacturing of high-end cardiovascular medical devices. It has a number of international PCT invention patents, and its innovative technology is in the leading position in the world.

3500 +

Implantation in mainland China

30 +

Implantation in Hong Kong, Macao and Taiwan

50 +

Implantation in North America

180 +

Global Cooperation Unit

10 +

international invention patent